Benzimidazole compound for the treatment of metabolic disorders
AssigneeAché LaboratóRios FarmacêUticos S.A.
InventorsHatylas Felype Zaneti De Azevedo, Marcos Antonio Ferreira Junior, Natanael Dante Segretti, Alessandra Mascarello, Cristiano Ruch Werneck Guimarães
Life of this patent
Estimating the term…
Abstract
The present invention broadly concerns a benzimidazole compound of formula (I) for the treatment of obesity, diabetes, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Formula (I) or pharmaceutically acceptable salts, crystals, hydrates, prodrugs, metabolites, or solvates thereof.
Claims4
A method for the treatment of a metabolic disorder selected from the group consisting of obesity, diabetes, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis comprising administering a benzimidazole compound of formula I:
- or pharmaceutically acceptable salts, crystals, hydrates, solvates, prodrugs or metabolites thereof, to a patient.
Dependencies are inferred from the claim text.